PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Protara Therapeutics, Inc.
Filed: June 30, 2017
Period of Report: June 30, 2017
Accession Number: 0001171843-17-003907

View Document ↗ View on SEC.gov ↗